RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chengdu Kanghua Biological Products Co Stock

Chengdu Kanghua Biological Products Co Liabilities 2024

Chengdu Kanghua Biological Products Co Liabilities

695.22 M CNY

Ticker

300841.SZ

ISIN

CNE100003Y57

In 2024, Chengdu Kanghua Biological Products Co's total liabilities amounted to 695.22 M CNY, a 9.41% difference from the 635.4 M CNY total liabilities in the previous year.

Chengdu Kanghua Biological Products Co Aktienanalyse

What does Chengdu Kanghua Biological Products Co do?

Chengdu Kanghua Biological Products Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Chengdu Kanghua Biological Products Co's Liabilities

Chengdu Kanghua Biological Products Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Chengdu Kanghua Biological Products Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Chengdu Kanghua Biological Products Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Chengdu Kanghua Biological Products Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Chengdu Kanghua Biological Products Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Chengdu Kanghua Biological Products Co stock

What is the level of liabilities of Chengdu Kanghua Biological Products Co this year?

Chengdu Kanghua Biological Products Co has a debt balance of 695.22 M CNY this year.

What were the liabilities of Chengdu Kanghua Biological Products Co compared to the previous year?

The liabilities of Chengdu Kanghua Biological Products Co have increased by 9.41% increased compared to the previous year.

What are the consequences of high debt for investors of Chengdu Kanghua Biological Products Co?

High liabilities can pose a risk for investors of Chengdu Kanghua Biological Products Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Chengdu Kanghua Biological Products Co?

Low liabilities mean that Chengdu Kanghua Biological Products Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Chengdu Kanghua Biological Products Co affect the company?

An increase in liabilities of Chengdu Kanghua Biological Products Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Chengdu Kanghua Biological Products Co affect the company?

A decrease in the liabilities of Chengdu Kanghua Biological Products Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Chengdu Kanghua Biological Products Co?

Some factors that can influence the liabilities of Chengdu Kanghua Biological Products Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Chengdu Kanghua Biological Products Co so important for investors?

The liabilities of Chengdu Kanghua Biological Products Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Chengdu Kanghua Biological Products Co take to modify the liabilities?

To change its liabilities, Chengdu Kanghua Biological Products Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Chengdu Kanghua Biological Products Co pay?

Over the past 12 months, Chengdu Kanghua Biological Products Co paid a dividend of 0.5 CNY . This corresponds to a dividend yield of about 0.95 %. For the coming 12 months, Chengdu Kanghua Biological Products Co is expected to pay a dividend of 0.58 CNY.

What is the dividend yield of Chengdu Kanghua Biological Products Co?

The current dividend yield of Chengdu Kanghua Biological Products Co is 0.95 %.

When does Chengdu Kanghua Biological Products Co pay dividends?

Chengdu Kanghua Biological Products Co pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Chengdu Kanghua Biological Products Co?

Chengdu Kanghua Biological Products Co paid dividends every year for the past 6 years.

What is the dividend of Chengdu Kanghua Biological Products Co?

For the upcoming 12 months, dividends amounting to 0.58 CNY are expected. This corresponds to a dividend yield of 1.1 %.

In which sector is Chengdu Kanghua Biological Products Co located?

Chengdu Kanghua Biological Products Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chengdu Kanghua Biological Products Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chengdu Kanghua Biological Products Co from 5/8/2024 amounting to 2 CNY, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.

When did Chengdu Kanghua Biological Products Co pay the last dividend?

The last dividend was paid out on 5/8/2024.

What was the dividend of Chengdu Kanghua Biological Products Co in the year 2023?

In the year 2023, Chengdu Kanghua Biological Products Co distributed 1 CNY as dividends.

In which currency does Chengdu Kanghua Biological Products Co pay out the dividend?

The dividends of Chengdu Kanghua Biological Products Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chengdu Kanghua Biological Products Co

Our stock analysis for Chengdu Kanghua Biological Products Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chengdu Kanghua Biological Products Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.